Specifically, in CRC, a recent comprehensive analysis of 2.314 cases showed how the frequency of kinase gene fusions in an unselected population is about 0.9%, but it significantly increases in MSI-high (MSI-H) tumors (5%) and overall in RAS/BRAF wild type cancers (15%) [19]. This evidence concerns the gene BRAF and cancer.